← All companies

HCA Healthcare (HCA)

Hold Current rating · 5 reports

Coverage summary

Aardvark Labs Capital Research has covered HCA Healthcare (HCA) since October 25, 2025. The company is in the Healthcare sector. This page lists 5 reports: 5 earnings recaps.

The latest is the Q3 2026 Earnings Recap, published October 28, 2026. The current rating is Hold, unchanged since the Q2 2026 Earnings Recap of July 25, 2026. The rating has changed twice since coverage began.

Translations: 4 in Chinese.

Rating history

  1. First rating: Hold Q3 2025 Earnings Recap
  2. Hold → Outperform Q1 2026 Earnings Recap
  3. Outperform → Hold Q2 2026 Earnings Recap

All HCA reports

2026-10-28

Hold Recap: Q3 2026

The Best Operating Quarter of the Coverage, and Management Capped 2027 Before Anyone Could Model It
2026-07-25

Hold Recap: Q2 2026

One-for-One: Every Lost Exchange Patient Became an Uninsured One, and Our Upgrade Was Wrong
2026-04-25

Outperform Recap: Q1 2026

The Flu Never Came, the Cliff Landed Soft: Upgrading Into an 8.8% De-Rating
2026-01-28

Hold Recap: Q4 2025

The Cliff Gets a Number, and the Number Is Survivable. The Growth Is Not.
2025-10-25

Hold Recap: Q3 2025

The Beat Is Real; the Repeat Belongs to Washington